aTyr Pharma
Stock Forecast, Prediction & Price Target
aTyr Pharma Financial Estimates
aTyr Pharma Revenue Estimates
aTyr Pharma EBITDA Estimates
aTyr Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $10.38M 0% | $353K -96.60% | Avg: $7.45M Low: $7.32M High: $7.63M avg. 2012.52% | Avg: $81.73M Low: $80.25M High: $83.70M avg. 996.06% | Avg: $184.66M Low: $181.33M High: $189.11M avg. 125.93% | Avg: $429.18M Low: $421.42M High: $439.52M avg. 132.40% |
Net Income
% change YoY
| $-32.46M N/A | $-44.27M -36.38% | $-50.38M -13.80% | Avg: $-58.63M Low: $-55.21M High: $-27.33M avg. -16.35% | Avg: $-6.13M Low: $-28.41M High: $35.38M avg. 89.53% | Avg: $42.56M Low: $41.56M High: $43.89M avg. 793.71% | Avg: $147.95M Low: $144.47M High: $152.58M avg. 247.60% |
EBITDA
% change YoY
| $-34.01M N/A | $-46.40M -36.42% | $-52.17M -12.44% | Avg: $-4.47M Low: $-4.58M High: $-4.39M avg. 91.42% | Avg: $-49.04M Low: $-50.22M High: $-48.15M avg. -996.06% | Avg: $-110.80M Low: $-113.47M High: $-108.79M avg. -125.93% | Avg: $-257.51M Low: $-263.71M High: $-252.85M avg. -132.40% |
EPS
% change YoY
| -$1.7 N/A | -$1.56 8.23% | -$0.94 39.74% | Avg: -$0.75 Low: -$1.03 High: -$0.51 avg. 20.42% | Avg: -$0.04 Low: -$0.53 High: $0.66 avg. 94.11% | Avg: $0.79 Low: $0.78 High: $0.82 avg. 1904.54% | Avg: $2.76 Low: $2.7 High: $2.85 avg. 247.60% |
Operating Expenses
% change YoY
| $34.01M N/A | $56.79M 66.95% | $52.53M -7.49% | Avg: $81.10M Low: $79.63M High: $83.05M avg. 54.38% | Avg: $888.92M Low: $872.86M High: $910.34M avg. 996.06% | Avg: $2.00B Low: $1.97B High: $2.05B avg. 125.93% | Avg: $4.66B Low: $4.58B High: $4.78B avg. 132.40% |
FAQ
What is aTyr Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 278.62% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -55.21M, average is -58.63M and high is -27.33M.
What is aTyr Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 816.73% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $7.32M, average is $7.45M and high is $7.63M.
What is aTyr Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 566.67% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.03, average is -$0.75 and high is $-0.51.
What is the best performing analyst?
In the last twelve months analysts have been covering aTyr Pharma stock. The most successful analyst is Edward Tenthoff.